Bristol-Myers Squibb (BMY) option IV into acquiring Karuna Therapeutics (KRTX)
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $66.92 +0.16%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 4.5%
Revenue Growth %: +3.2%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 4.5%
Revenue Growth %: +3.2%
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) 30-day option implied volatility is at 25; compared to its 52-week range of 16 to 26 into acquiring Karuna Therapeutics (KRTX) for $14B.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMS presents five-year Camzyos data for heart condition at ESC
- Sempra Energy (SRE) call put ratio 1.1 calls to 1 put as share price up 3.2%
- Five Below (FIVE) call put ratio 1 call to 1.3 puts into quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, krtxSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
